CF Pharmtech Guangzhou Ltd. and CF Pharmtech Hongkong Ltd. have identified prodrugs of treprostinil reported to be useful for the treatment of pulmonary hypertension and pulmonary fibrosis.

But using two or more drugs combined in a single platform, forming prodrugs that can target different aspects of cancer, could end up being a very effective treatment strategy. Imagine a thrilling ...

The prodrugs eventually dissociate to release the active ingredient in a controlled manner, according to Ascendis. The company has already demonstrated the value of its technology in two approved ...